Alerts will be sent to your verified email
Verify EmailOMKARPH
|
Omkar Pharmachem
|
Norris Medicines
|
Desh Rakshak Aushdh
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
2.2 % | 25.68 % | 4.74 % |
|
5yr average Equity Multiplier
|
1.05 | -1.27 | 1.73 |
|
5yr Average Asset Turnover Ratio
|
0.05 | 0.6 | 0.39 |
|
5yr Avg Net Profit Margin
|
44.95 % | -27.67 % | 7.09 % |
|
Price to Book
|
0.44 | 0.0 | 1.35 |
|
P/E
|
136.27 | 0.0 | 31.38 |
|
5yr Avg Cash Conversion Cycle
|
49.27 Days | 113.0 Days | -280.35 Days |
|
Inventory Days
|
0.0 | 182.62 Days | 36.63 Days |
|
Days Receivable
|
49.27 Days | 77.44 Days | 363.29 Days |
|
Days Payable
|
0.0 | 195.35 Days | 408.55 Days |
|
5yr Average Interest Coverage Ratio
|
7.4 | -1.07 | 2.89 |
|
5yr Avg ROCE
|
2.6 % | -18.91 % | 6.6 % |
|
5yr Avg Operating Profit Margin
|
44.39 % | -2.35 % | 19.52 % |
|
5 yr average Debt to Equity
|
0.06 | -1.84 | 0.38 |
|
5yr CAGR Net Profit
|
-1.89 % | -24.21 % | 2.71 % |
|
5yr Average Return on Assets
|
2.09 % | -17.47 % | 2.74 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.03 % | 34.01 % | 50.03 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.03 % | -14.25 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Omkar Pharmachem
|
Norris Medicines
|
Desh Rakshak Aushdh
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|